Drug Profile
Sumatriptan needle-free injectable - Glide/Endo
Alternative Names: Glide sumatriptan; GP-01; Sumatriptan SDILatest Information Update: 21 Oct 2021
Price :
$50
*
At a glance
- Originator Glide Pharma
- Developer Endo International; Glide Technologies
- Class Antimigraines; Indoles; Small molecules; Sulfonamides; Tryptamines
- Mechanism of Action Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 17 Mar 2011 Phase-II clinical trials in Migraine in Canada (SC)